http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003021784-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
| filingDate | 2001-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42e71cba639bc9054d44fd8fbbaf824a |
| publicationDate | 2003-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003021784-A1 |
| titleOfInvention | 33200, a novel human dehydrogenase/reductase family member and uses thereof |
| abstract | The invention provides isolated nucleic acids molecules, designated 33200 nucleic acid molecules, which encode novel dehydrogenase/reductase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 33200 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 33200 gene has been introduced or disrupted. The invention still further provides isolated 33200 proteins, fusion proteins, antigenic peptides and anti-33200 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
| priorityDate | 2000-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1703.